These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38194689)

  • 1. Clinical and functional spectrum of RAC2-related immunodeficiency.
    Donkó Á; Sharapova SO; Kabat J; Ganesan S; Hauck FH; Bergerson JRE; Marois L; Abbott J; Moshous D; Williams KW; Campbell N; Martin PL; Lagresle-Peyrou C; Trojan T; Kuzmenko NB; Deordieva EA; Raykina EV; Abers MS; Abolhassani H; Barlogis V; Milla C; Hall G; Mousallem T; Church J; Kapoor N; Cros G; Chapdelaine H; Franco-Jarava C; Lopez-Lerma I; Miano M; Leiding JW; Klein C; Stasia MJ; Fischer A; Hsiao KC; Martelius T; Seppänen MRJ; Barmettler S; Walter J; Masmas TN; Mukhina AA; Falcone EL; Kracker S; Shcherbina A; Holland SM; Leto TL; Hsu AP
    Blood; 2024 Apr; 143(15):1476-1487. PubMed ID: 38194689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects.
    Hsu AP; Donkó A; Arrington ME; Swamydas M; Fink D; Das A; Escobedo O; Bonagura V; Szabolcs P; Steinberg HN; Bergerson J; Skoskiewicz A; Makhija M; Davis J; Foruraghi L; Palmer C; Fuleihan RL; Church JA; Bhandoola A; Lionakis MS; Campbell S; Leto TL; Kuhns DB; Holland SM
    Blood; 2019 May; 133(18):1977-1988. PubMed ID: 30723080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation.
    Zhang L; Chen Z; Li W; Liu Q; Wang Y; Chen X; Tian Z; Yang Q; An Y; Zhang Z; Mao H; Tang X; Lv G; Zhao X
    J Clin Immunol; 2022 Aug; 42(6):1280-1292. PubMed ID: 35596857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and biological characterization of a human Rac2 GTPase mutant associated with phagocytic immunodeficiency.
    Gu Y; Jia B; Yang FC; D'Souza M; Harris CE; Derrow CW; Zheng Y; Williams DA
    J Biol Chem; 2001 May; 276(19):15929-38. PubMed ID: 11278678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation.
    Ambruso DR; Knall C; Abell AN; Panepinto J; Kurkchubasche A; Thurman G; Gonzalez-Aller C; Hiester A; deBoer M; Harbeck RJ; Oyer R; Johnson GL; Roos D
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4654-9. PubMed ID: 10758162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAC2 and primary human immune deficiencies.
    Lougaris V; Baronio M; Gazzurelli L; Benvenuto A; Plebani A
    J Leukoc Biol; 2020 Aug; 108(2):687-696. PubMed ID: 32542921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoattractant-stimulated Rac activation in wild-type and Rac2-deficient murine neutrophils: preferential activation of Rac2 and Rac2 gene dosage effect on neutrophil functions.
    Li S; Yamauchi A; Marchal CC; Molitoris JK; Quilliam LA; Dinauer MC
    J Immunol; 2002 Nov; 169(9):5043-51. PubMed ID: 12391220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency.
    Williams DA; Tao W; Yang F; Kim C; Gu Y; Mansfield P; Levine JE; Petryniak B; Derrow CW; Harris C; Jia B; Zheng Y; Ambruso DR; Lowe JB; Atkinson SJ; Dinauer MC; Boxer L
    Blood; 2000 Sep; 96(5):1646-54. PubMed ID: 10961859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections.
    Sharapova SO; Haapaniemi E; Sakovich IS; Kostyuchenko LV; Donkó A; Dulau-Florea A; Malko O; Bondarenko AV; Stegantseva MV; Leto TL; Uygun V; Karasu GT; Holland SM; Hsu AP; Aleinikova OV
    Clin Immunol; 2019 Aug; 205():1-5. PubMed ID: 31071452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac GTPase isoform-specific regulation of NADPH oxidase and chemotaxis in murine neutrophils in vivo. Role of the C-terminal polybasic domain.
    Yamauchi A; Marchal CC; Molitoris J; Pech N; Knaus U; Towe J; Atkinson SJ; Dinauer MC
    J Biol Chem; 2005 Jan; 280(2):953-64. PubMed ID: 15504745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rac2 regulates neutrophil chemotaxis, superoxide production, and myeloid colony formation through multiple distinct effector pathways.
    Carstanjen D; Yamauchi A; Koornneef A; Zang H; Filippi MD; Harris C; Towe J; Atkinson S; Zheng Y; Dinauer MC; Williams DA
    J Immunol; 2005 Apr; 174(8):4613-20. PubMed ID: 15814684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases.
    Gu Y; Filippi MD; Cancelas JA; Siefring JE; Williams EP; Jasti AC; Harris CE; Lee AW; Prabhakar R; Atkinson SJ; Kwiatkowski DJ; Williams DA
    Science; 2003 Oct; 302(5644):445-9. PubMed ID: 14564009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2.
    Arrington ME; Temple B; Schaefer A; Campbell SL
    J Biol Chem; 2020 Aug; 295(34):12130-12142. PubMed ID: 32636302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of Rac2 via the C terminus and aspartic acid 150 specifies superoxide generation, actin polarity and chemotaxis in neutrophils.
    Filippi MD; Harris CE; Meller J; Gu Y; Zheng Y; Williams DA
    Nat Immunol; 2004 Jul; 5(7):744-51. PubMed ID: 15170212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac2 expression and its role in neutrophil functions of zebrafish (Danio rerio).
    Tell RM; Kimura K; Palić D
    Fish Shellfish Immunol; 2012 Nov; 33(5):1086-94. PubMed ID: 22992407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rac2 is an essential regulator of neutrophil nicotinamide adenine dinucleotide phosphate oxidase activation in response to specific signaling pathways.
    Kim C; Dinauer MC
    J Immunol; 2001 Jan; 166(2):1223-32. PubMed ID: 11145705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAC2 GTPase deficiency and myeloid cell dysfunction in human and mouse.
    Gu Y; Williams DA
    J Pediatr Hematol Oncol; 2002 Dec; 24(9):791-4. PubMed ID: 12468931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rac GTPases in human diseases.
    Pai SY; Kim C; Williams DA
    Dis Markers; 2010; 29(3-4):177-87. PubMed ID: 21178276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Loss of Function (G15D) Mutation on RAC2 in a Family with Combined Immunodeficiency and Increased Levels of Immunoglobulin G, A, and E.
    Duan X; Shen F; Deng Y; Zhang J; Fang F; Luo Z; Chen Y; Yang Y
    J Clin Immunol; 2023 Apr; 43(3):604-614. PubMed ID: 36459342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation.
    Doye A; Chaintreuil P; Lagresle-Peyrou C; Batistic L; Marion V; Munro P; Loubatier C; Chirara R; Sorel N; Bessot B; Bronnec P; Contenti J; Courjon J; Giordanengo V; Jacquel A; Barbry P; Couralet M; Aladjidi N; Fischer A; Cavazzana M; Mallebranche C; Visvikis O; Kracker S; Moshous D; Verhoeyen E; Boyer L
    J Exp Med; 2024 Oct; 221(10):. PubMed ID: 39212656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.